stackBETA

Daily

  • Log

Verify

  • Cabinet · stacks
  • Vials · inventory

Build

  • Reconstitution

Plan

  • Can I get it?
  • Compare
  • Synergy check

Learn

  • Encyclopedia
  • Common stacks
  • Pulse
  • Methodology

Info

  • Partners & programs

Stack · v0.1 beta

stackBETAv0.1
LogEncyclopediaPulse
MethodologyPartners & programs
← Back to your stack
Monograph
FDA CAT. 1P-073
Aesthetics

Matrixyl 3000 (Palmitoyl Pentapeptide-4)

Synthetic pentapeptide (Pal-KTTKS) developed by Sederma. Mimics a procollagen-I fragment; topically signals fibroblasts to upregulate collagen + glycosaminoglycan synthesis.

EmergingAesthetics
Typical doseTopical: 2-5% concentration in serum
Frequencytwice daily, topical
Half-life12h
Citations indexed26
100%50%0%012h1d1.5d2d2.5dt½ 12hPK · plasma

How it clearsHalf cleared in ~12h. Most (~96%) gone by ~3d.

DeliveryTopical
Half-life~12h
EvidenceEmerging
Citations26
Similar compounds
Stack Pro · compare side-by-side

Compare these compounds

Mechanism, evidence, legal path, cost — all side-by-side.

→
Synergy checkCompare
Mechanism

Robinson 2005 RCT (N=93) showed measurable wrinkle-depth reduction over 12 weeks daily application — became the foundational cosmeceutical-peptide trial. Matrixyl 3000 is the blended formula (Pal-KTTKS + Pal-Glycyl-Histidyl-Lysine) that Sederma trademarked; it's now in hundreds of mid-to-premium skincare formulations. Like Argireline, real effect is modest but consistent.

Specifics
Skin agingSkin tone & texture
Caveats

Effect emerges over 8-12 weeks of consistent use — not an overnight intervention. Stratum-corneum penetration depends on formulation quality. Stacking with retinoids amplifies irritation risk in sensitive skin types.

Evidence levelEmerging
Regulatory statusCosmetic-ingredient classification (US/EU/MX) · widely sold OTC across mid-premium skincare
DNA / pharmacogenomicsLow — No actionable PG.
Your data · empty

Upload your data to see how it relates to Matrixyl 3000.

Upload a lab file (LabCorp / Quest) or DNA file (23andMe / AncestryDNA). Stack will show your specific markers alongside the literature-reported response windows.

Upload in /history→
Claims & evidence

Per-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.

  • CLimited evidence

    Matrixyl 3000 (Palmitoyl Pentapeptide-4) — primary mechanism: synthetic pentapeptide (pal-kttks) developed by sederma. mimics a procollagen-i fragment; topically signals fibroblasts to upregulate collagen + glycosaminoglycan synthesis.

    1 supporting referencesVerified 13d ago
References

External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.

  • PubMedEN
    RCTIndustry-fundedVerified 13d ago
    Robinson LR et al, Int J Cosmet Sci 2005 — Pal-KTTKS wrinkle RCT
FDA CAT. 1P-073

Cosmetic-ingredient classification (US/EU/MX) · widely sold OTC across mid-premium skincare

Can I get it? →

No field reports yet

Field reports are added as users share their real-world protocols.

Matrixyl 3000Topical: 2-5% concentration in serum · twice daily, topical

Next visit & citations

Handoff & sources

Running this compound? Log it in /history, then open Dr Passport before your visit. Methodology explains grades; the research dashboard sorts the full catalog with citations.

Open Dr PassportMethodologyResearch tableClinician primer
Discussion guide, not prescription

stack is an exploration engine. Output is a discussion guide for a conversation with a licensed provider — never a prescription, dose recommendation, or sourcing instruction. Peptides discussed include compounds with limited human evidence and varying legal status by jurisdiction. Verify everything with a qualified clinician before any decision.

Full terms →
stackv0.1
AudiencesPartners & programsWho Stack is forFor creatorsFor researchersFor pharmaciesFor cliniciansFor press
Trust & regulatoryCalibrationMethodologyFDA statusPharmacy registryPCAC commentMX · COFEPRIS
Built honest. Bilingual from day one.
TodayLibrary
ToolsMe